Cargando…
Glucocorticoid-induced enhancement of extinction—from animal models to clinical trials
Extensive evidence from both animal model and human research indicates that glucocorticoid hormones are crucially involved in modulating memory performance. Glucocorticoids, which are released during stressful or emotionally arousing experiences, enhance the consolidation of new memories, including...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373196/ https://www.ncbi.nlm.nih.gov/pubmed/30610352 http://dx.doi.org/10.1007/s00213-018-5116-0 |
_version_ | 1783394929140039680 |
---|---|
author | de Quervain, Dominique Wolf, Oliver T. Roozendaal, Benno |
author_facet | de Quervain, Dominique Wolf, Oliver T. Roozendaal, Benno |
author_sort | de Quervain, Dominique |
collection | PubMed |
description | Extensive evidence from both animal model and human research indicates that glucocorticoid hormones are crucially involved in modulating memory performance. Glucocorticoids, which are released during stressful or emotionally arousing experiences, enhance the consolidation of new memories, including extinction memory, but reduce the retrieval of previously stored memories. These memory-modulating properties of glucocorticoids have recently received considerable interest for translational purposes because strong aversive memories lie at the core of several fear-related disorders, including post-traumatic stress disorder and phobias. Moreover, exposure-based psychological treatment of these disorders relies on successful fear extinction. In this review, we argue that glucocorticoid-based interventions facilitate fear extinction by reducing the retrieval of aversive memories and enhancing the consolidation of extinction memories. Several clinical trials have already indicated that glucocorticoids might be indeed helpful in the treatment of fear-related disorders. |
format | Online Article Text |
id | pubmed-6373196 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-63731962019-03-22 Glucocorticoid-induced enhancement of extinction—from animal models to clinical trials de Quervain, Dominique Wolf, Oliver T. Roozendaal, Benno Psychopharmacology (Berl) Review Extensive evidence from both animal model and human research indicates that glucocorticoid hormones are crucially involved in modulating memory performance. Glucocorticoids, which are released during stressful or emotionally arousing experiences, enhance the consolidation of new memories, including extinction memory, but reduce the retrieval of previously stored memories. These memory-modulating properties of glucocorticoids have recently received considerable interest for translational purposes because strong aversive memories lie at the core of several fear-related disorders, including post-traumatic stress disorder and phobias. Moreover, exposure-based psychological treatment of these disorders relies on successful fear extinction. In this review, we argue that glucocorticoid-based interventions facilitate fear extinction by reducing the retrieval of aversive memories and enhancing the consolidation of extinction memories. Several clinical trials have already indicated that glucocorticoids might be indeed helpful in the treatment of fear-related disorders. Springer Berlin Heidelberg 2019-01-04 2019 /pmc/articles/PMC6373196/ /pubmed/30610352 http://dx.doi.org/10.1007/s00213-018-5116-0 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Review de Quervain, Dominique Wolf, Oliver T. Roozendaal, Benno Glucocorticoid-induced enhancement of extinction—from animal models to clinical trials |
title | Glucocorticoid-induced enhancement of extinction—from animal models to clinical trials |
title_full | Glucocorticoid-induced enhancement of extinction—from animal models to clinical trials |
title_fullStr | Glucocorticoid-induced enhancement of extinction—from animal models to clinical trials |
title_full_unstemmed | Glucocorticoid-induced enhancement of extinction—from animal models to clinical trials |
title_short | Glucocorticoid-induced enhancement of extinction—from animal models to clinical trials |
title_sort | glucocorticoid-induced enhancement of extinction—from animal models to clinical trials |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373196/ https://www.ncbi.nlm.nih.gov/pubmed/30610352 http://dx.doi.org/10.1007/s00213-018-5116-0 |
work_keys_str_mv | AT dequervaindominique glucocorticoidinducedenhancementofextinctionfromanimalmodelstoclinicaltrials AT wolfolivert glucocorticoidinducedenhancementofextinctionfromanimalmodelstoclinicaltrials AT roozendaalbenno glucocorticoidinducedenhancementofextinctionfromanimalmodelstoclinicaltrials |